Torisel

DRUG3 trials

Sponsors

Pfizer, Oncology Specialists, S.C., Chinese University of Hong Kong

Conditions

AdenocarcinomaInoperable HCCNeoplasmsProstate Cancer

Phase 1

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

CompletedNCT00106353

PfizerAdenocarcinoma, Neoplasms

Start: 2005-03-31End: 2012-01-31Updated: 2013-02-08

Hepatocellular Carcinoma (HCC)_Torisel_

CompletedNCT01251458

Chinese University of Hong KongInoperable HCC

Start: 2009-10-31End: 2016-01-31Updated: 2016-09-28

Phase 2

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

CompletedNCT00919035

Oncology Specialists, S.C.Prostate Cancer

Start: 2009-06-30End: 2013-10-31Updated: 2014-06-30